2020
DOI: 10.1016/j.htct.2020.10.892
|View full text |Cite
|
Sign up to set email alerts
|

D-Dímero Elevado Em Pacientes Com Covid-19: Relato De Uma Seguimento Clínico E Laboratorial Em 6 Casos Confirmados

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
2
1
1

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 0 publications
0
2
1
1
Order By: Relevance
“…It was observed that of the patients in the present study, 27.59% had Ddimer levels six times higher than the reference value, while 17.24% had values ten times higher than the established reference value, which was 500 ng/dL. Elevation of the D-dimer is associated with an intense inflammatory reaction from the viral infection, as well as a greater risk of thromboembolic events during infection with the new coronavirus, which worsens the prognosis and increases the death rate (ROCHA et al, 2020).…”
Section: Discussioncontrasting
confidence: 44%
“…It was observed that of the patients in the present study, 27.59% had Ddimer levels six times higher than the reference value, while 17.24% had values ten times higher than the established reference value, which was 500 ng/dL. Elevation of the D-dimer is associated with an intense inflammatory reaction from the viral infection, as well as a greater risk of thromboembolic events during infection with the new coronavirus, which worsens the prognosis and increases the death rate (ROCHA et al, 2020).…”
Section: Discussioncontrasting
confidence: 44%
“…It was also observed that critically ill patients hospitalized the ICU had significantly higher values for D-dimer markers. Nonetheless, changes in relation to D-dimer can be predictors of severity and reflect in poor prognosis, mainly associated with thrombotic events [ 24 ]. A prospective cohort study demonstrated a 10% increase in mortality risk for every 10% increase in interleukin (IL)−6 or D-dimer levels [ 22 ].…”
Section: Discussionmentioning
confidence: 99%
“…Finally, ROS and D-dimer presented a relationship, since they were associated with an increased risk of needing to be hospitalized in the ICU. This relationship appear, once, the immune response leads to excessive production and accumulation of ROS, that cause clinical signs characteristic of COVID-19, such as decreased oxygen saturation, vasoconstriction, elevated cytokines, alteration of hemoglobin properties, cardiac and/or renal injury and enhanced D-dimer [ 32 ], that reflects poor prognosis, mainly associated with thrombotic events [ 24 ].…”
Section: Discussionmentioning
confidence: 99%
“…(9) Los factores de riesgo para desarrollar TEP son algo inespecíficos y muchos de estos representarán un riesgo franco para la presentación de TEP asociada a COVID-19, sin embargo, varían entre pacientes y es por esto que no se puede generalizar quienes van a presentar esta complicación y quienes van a ser esquivos a la misma, a pesar de esto se debe conocer dichos factores y tenerlos en cuenta en todo momento. (6,10) Existen múltiples factores de riesgo con influencia en la presentación de TEP relacionado a COVID-19, así por mencionar algunos se sabe que los pacientes que precisan ingreso a UCI tienen un mayor riesgo de desarrollar TEP que aquellos pacientes que se mantienen en planta de hospitalización, (11,12) el aumento de dímero D (DD) se ha visto también asociado con patología trombótica además de relacionarse a un mayor índice de mortalidad, así también la presencia de comorbilidades como la obesidad aumenta el riesgo de contagio y la necesidad de intubación, (11,13,14) incluso a cierta edad se aumenta el riesgo embolias venosas y debe ser considerado como un factor a tomar en cuenta. (15,16) Esta investigación busca dar a conocer algunos de los factores de riesgo que se asocian al desarrollo de TEP en pacientes con COVID-19, con el fin de contribuir a integrar el conocimiento científico como base teórica para el desarrollo de estrategias de prevención y con el objetivo de llegar no solo al conocimiento del personal de salud sino además de la población en general y así poder garantizar una mayor supervivencia de los pacientes además de evitar el colapso de los sistemas de salud como fue evidente en un inicio de la pandemia.…”
Section: Introductionunclassified